BioWorld MedTech

Aug. 26, 2014

View Archived Issues

FDA approves Medtronic Viva CRT-P for HF with AdaptiveCRT algorithm

Medtronic (Minneapolis) reported FDA approval and U.S. launch of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with heart failure or atrioventricular (AV) block. Read More

Asia in the Spotlight: MC Medical signs agreement for FloShield distribution rights in Japan

Read More

Inside the Beltway: FDA final IDE decisions guidance not explicit on 'new developments'

Read More

Latin America: Covidien premieres new $25 million physician training center in Brazil

Read More

Daily M&A: Golden Medtech to purchase China Cord Blood note for $88.1 million

Read More

World in Review: Kips Bay Medical receives updated CE mark for new use of its eSVS mesh

Read More

Agreements/Contracts: Telik gets NCI support for preclincial research on PET

Read More

Restructuring: Biolase creates commmercilization team, board makes two appointments

Read More

Courts: ITC rules in patent infringement case brought on by ResMed

Read More

Patent Watch: InHealth Technologies releases Blom-Singer for sale in U.S.

Read More

product briefs

Read More

MDD's Cardiology Extra

Read More